Symbols / USNA Stock $19.44 +1.04% USANA Health Sciences, Inc.

Consumer Defensive • Packaged Foods • United States • NYQ
USNA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Consumer Defensive
Industry Packaged Foods
CEO Mr. Kevin G. Guest
Exch · Country NYQ · United States
Market Cap 358.80M
Enterprise Value 285.55M
Income 10.76M
Sales 925.26M
FCF (ttm) 36.85M
Book/sh 29.16
Cash/sh 8.58
Employees 1,570
Insider 10d
IPO Apr 04, 1994
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 33.52
Forward P/E 7.02
PEG 0.81
P/S 0.39
P/B 0.67
P/C
EV/EBITDA 3.42
EV/Sales 0.31
Quick Ratio 1.30
Current Ratio 2.24
Debt/Eq 5.45
LT Debt/Eq
EPS (ttm) 0.58
EPS next Y 2.77
EPS Growth
Revenue Growth 5.90%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-17
ROA 4.26%
ROE 1.96%
ROIC
Gross Margin 78.29%
Oper. Margin 7.63%
Profit Margin 1.16%
Shs Outstand 18.46M
Shs Float 9.69M
Insider Own 40.88%
Instit Own 57.22%
Short Float 4.38%
Short Ratio 3.86
Short Interest 477.88K
52W High 38.32
vs 52W High -49.27%
52W Low 16.60
vs 52W Low 17.11%
Beta 0.70
Impl. Vol. 1.46%
Rel Volume 0.54
Avg Volume 129.58K
Volume 70.61K
Target (mean) $39.00
Tgt Median $39.00
Tgt Low $39.00
Tgt High $39.00
# Analysts 1
Recom Strong_buy
Prev Close $19.24
Price $19.44
Change 1.04%
About

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$19.44
Low
$39.00
High
$39.00
Mean
$39.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-02-27 main DA Davidson Neutral → Neutral $36
2025-01-02 main DA Davidson Neutral → Neutral $38
2024-10-23 main DA Davidson Neutral → Neutral $35
2024-07-25 main DA Davidson Neutral → Neutral $38
2024-05-07 main DA Davidson Neutral → Neutral $46
2024-02-22 main DA Davidson Neutral → Neutral $48
2023-10-25 main DA Davidson Neutral → Neutral $53
2023-04-26 main DA Davidson — → Neutral $56
2023-02-13 main DA Davidson — → Neutral $53
2022-10-27 main DA Davidson — → Neutral $49
2022-07-28 main DA Davidson — → Neutral $57
2022-07-12 main DA Davidson — → Neutral $58
2022-07-07 down Jefferies Hold → Underperform $53
2022-04-27 main DA Davidson — → Neutral $76
2022-04-14 init DA Davidson — → Neutral $86
2021-02-10 main Roth Capital — → Buy $126
2020-12-17 init Roth Capital — → Buy $107
2019-08-22 init Jefferies — → Hold $65
2019-07-03 down Sidoti & Co. Buy → Neutral $70
2019-04-16 init Tigress Financial — → Buy
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 FULLER GILBERT A Director 1,058 $17.00 $17,986
2026-03-03 BENEDICT PETER Chief Technology Officer 4,553 $19.38 $88,259
2026-02-27 GUEST KEVIN G Chief Executive Officer 7,856
2026-02-27 IIEKKING G DOUGLAS Chief Financial Officer 7,469
2026-02-27 NOOT WALTER Chief Operating Officer 7,422
2026-02-27 FOUKAS JOSHUA Officer 6,577
2026-02-27 NEIDIG BRENT Officer 6,747
2026-02-27 BENEDICT PETER Chief Technology Officer 3,906
2026-02-27 ARMSTRONG KATHRYN MICHELLE PH.D. Officer 4,190
2026-02-27 JONES PAUL A Officer 4,596
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
925.26
+8.28%
854.50
-7.22%
921.01
-7.77%
998.60
Operating Revenue
925.26
+8.28%
854.50
-7.22%
921.01
-7.77%
998.60
Cost Of Revenue
200.85
+24.59%
161.21
-8.76%
176.69
-8.87%
193.89
Reconciled Cost Of Revenue
200.85
+24.59%
161.21
-8.76%
176.69
-8.87%
193.89
Gross Profit
724.40
+4.49%
693.29
-6.86%
744.32
-7.51%
804.71
Operating Expense
673.54
+7.43%
626.97
-3.73%
651.25
-6.58%
697.10
Selling General And Administration
337.37
+28.15%
263.27
+2.44%
256.99
-2.03%
262.30
Selling And Marketing Expense
394.26
-9.32%
434.79
General And Administrative Expense
337.37
+28.15%
263.27
+2.44%
256.99
-2.03%
262.30
Other Gand A
337.37
+28.15%
263.27
+2.44%
256.99
-2.03%
262.30
Other Operating Expenses
336.17
-7.57%
363.70
-7.75%
394.26
-9.32%
434.79
Total Expenses
874.39
+10.94%
788.18
-4.80%
827.94
-7.08%
890.99
Operating Income
50.86
-23.31%
66.32
-28.74%
93.07
-13.51%
107.61
Total Operating Income As Reported
37.43
-43.56%
66.32
-28.74%
93.07
-13.51%
107.61
EBITDA
82.07
-16.98%
98.86
-19.70%
123.11
-5.46%
130.22
Normalized EBITDA
95.50
-3.40%
98.86
-19.70%
123.11
-5.46%
130.22
Reconciled Depreciation
39.70
+78.60%
22.23
+8.99%
20.39
-4.74%
21.41
EBIT
42.37
-44.71%
76.63
-25.39%
102.72
-5.60%
108.81
Total Unusual Items
-13.43
Total Unusual Items Excluding Goodwill
-13.43
Special Income Charges
-13.43
Other Special Charges
6.46
Impairment Of Capital Assets
6.97
Net Income
10.76
-74.40%
42.03
-34.11%
63.79
-8.02%
69.35
Pretax Income
41.53
-45.61%
76.35
-25.48%
102.45
-5.68%
108.62
Net Non Operating Interest Income Expense
1.57
-85.75%
11.04
+17.74%
9.38
+160.63%
3.60
Interest Expense Non Operating
0.84
+199.64%
0.28
+7.25%
0.26
+36.46%
0.19
Net Interest Income
1.57
-85.75%
11.04
+17.74%
9.38
+160.63%
3.60
Interest Expense
0.84
+199.64%
0.28
+7.25%
0.26
+36.46%
0.19
Interest Income Non Operating
2.42
-78.66%
11.32
+17.45%
9.64
+154.34%
3.79
Interest Income
2.42
-78.66%
11.32
+17.45%
9.64
+154.34%
3.79
Other Income Expense
-10.91
-978.93%
-1.01
-14542.86%
0.01
+100.27%
-2.59
Other Non Operating Income Expenses
2.52
+349.46%
-1.01
-14542.86%
0.01
+100.27%
-2.59
Tax Provision
30.05
-12.37%
34.29
-11.31%
38.66
-1.54%
39.27
Tax Rate For Calcs
0.00
+90.48%
0.00
-44.30%
0.00
+4.14%
0.00
Tax Effect Of Unusual Items
-5.37
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
11.48
-72.71%
42.06
-34.06%
63.79
-8.02%
69.35
Net Income From Continuing Operation Net Minority Interest
10.76
-74.40%
42.03
-34.11%
63.79
-8.02%
69.35
Net Income From Continuing And Discontinued Operation
10.76
-74.40%
42.03
-34.11%
63.79
-8.02%
69.35
Net Income Continuous Operations
11.48
-72.71%
42.06
-34.06%
63.79
-8.02%
69.35
Minority Interests
-0.72
-2290.00%
-0.03
0.00
Normalized Income
18.82
-55.23%
42.03
-34.11%
63.79
-8.02%
69.35
Net Income Common Stockholders
10.76
-74.40%
42.03
-34.11%
63.79
-8.02%
69.35
Diluted EPS
0.58
-73.52%
2.19
-33.64%
3.30
-8.08%
3.59
Basic EPS
0.58
-73.71%
2.21
-33.83%
3.33
-7.65%
3.61
Basic Average Shares
18.54
-2.77%
19.06
-0.35%
19.13
-0.40%
19.21
Diluted Average Shares
18.57
-3.07%
19.16
-0.95%
19.34
+0.18%
19.31
Diluted NI Availto Com Stockholders
10.76
-74.40%
42.03
-34.11%
63.79
-8.02%
69.35
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
742.91
-0.71%
748.19
+18.24%
632.76
+6.07%
596.55
Current Assets
288.40
+3.30%
279.19
-33.17%
417.75
+8.68%
384.38
Cash Cash Equivalents And Short Term Investments
158.38
-12.87%
181.77
-44.99%
330.42
+14.56%
288.42
Cash And Cash Equivalents
158.38
-12.87%
181.77
-44.99%
330.42
+14.56%
288.42
Receivables
9.11
+10.73%
8.22
+14.19%
7.20
-0.17%
7.21
Other Receivables
8.09
+9.03%
7.42
+20.20%
6.17
+19.08%
5.18
Taxes Receivable
1.02
+26.37%
0.80
-21.87%
1.03
-49.31%
2.03
Inventory
102.61
+47.14%
69.73
+13.48%
61.45
-8.40%
67.09
Raw Materials
31.73
+29.73%
24.46
+23.24%
19.85
-8.85%
21.78
Work In Process
5.00
+38.51%
3.61
-23.26%
4.71
+9.85%
4.29
Finished Goods
65.87
+58.11%
41.66
+12.91%
36.90
-10.06%
41.03
Prepaid Assets
12.54
-8.82%
13.76
+20.76%
11.39
+0.11%
11.38
Current Deferred Assets
0.91
+2.24%
0.89
-24.30%
1.18
-62.59%
3.16
Other Current Assets
4.85
+0.94%
4.81
-21.13%
6.10
-14.39%
7.12
Total Non Current Assets
454.51
-3.09%
469.01
+118.13%
215.01
+1.34%
212.17
Net PPE
94.38
-0.19%
94.56
-5.26%
99.81
+2.09%
97.77
Gross PPE
228.96
+1.92%
224.65
-1.79%
228.75
+2.80%
222.52
Accumulated Depreciation
-134.58
-3.45%
-130.09
-0.89%
-128.94
-3.36%
-124.75
Properties
0.00
0.00
0.00
0.00
Land And Improvements
9.92
+3.58%
9.58
-4.03%
9.98
-0.11%
9.99
Buildings And Improvements
78.58
+2.49%
76.68
-1.45%
77.80
-0.34%
78.07
Machinery Furniture Equipment
68.43
+1.85%
67.18
+7.80%
62.32
-1.56%
63.31
Construction In Progress
5.80
+25.50%
4.62
-52.89%
9.81
+61.27%
6.08
Other Properties
55.39
+2.60%
53.98
-0.96%
54.50
+7.54%
50.68
Leases
10.84
-14.05%
12.61
-12.04%
14.34
-0.35%
14.39
Goodwill And Other Intangible Assets
271.11
-8.40%
295.99
+529.49%
47.02
-5.58%
49.80
Goodwill
137.96
-4.30%
144.17
+742.99%
17.10
-1.53%
17.37
Other Intangible Assets
133.15
-12.30%
151.82
+407.45%
29.92
-7.75%
32.43
Non Current Deferred Assets
27.21
+38.51%
19.64
+47.88%
13.28
+35.56%
9.80
Non Current Deferred Taxes Assets
27.21
+38.51%
19.64
+47.88%
13.28
+35.56%
9.80
Other Non Current Assets
61.80
+5.10%
58.81
+7.13%
54.89
+0.18%
54.80
Total Liabilities Net Minority Interest
156.64
-3.22%
161.86
+19.41%
135.56
-16.36%
162.08
Current Liabilities
128.56
-7.92%
139.62
+17.48%
118.84
-17.37%
143.83
Payables And Accrued Expenses
38.08
+2.06%
37.31
+15.35%
32.35
+18.68%
27.26
Payables
28.58
+20.37%
23.74
+5.07%
22.60
-17.09%
27.26
Accounts Payable
17.26
+44.05%
11.98
+19.01%
10.07
-8.86%
11.05
Current Accrued Expenses
9.50
-29.99%
13.57
+39.17%
9.75
Pensionand Other Post Retirement Benefit Plans Current
20.65
+30.39%
15.84
-2.23%
16.20
-6.55%
17.33
Total Tax Payable
11.32
-3.77%
11.76
-6.14%
12.53
-22.70%
16.21
Income Tax Payable
3.37
-9.19%
3.71
+12.53%
3.30
-33.70%
4.97
Current Debt And Capital Lease Obligation
19.65
-32.27%
29.01
+259.78%
8.06
+17.01%
6.89
Current Debt
14.00
-39.13%
23.00
+2826.21%
0.79
Current Capital Lease Obligation
5.65
-6.04%
6.01
-17.38%
7.28
+5.60%
6.89
Current Deferred Liabilities
10.64
-11.70%
12.05
-13.37%
13.91
-33.37%
20.88
Current Deferred Revenue
10.64
-11.70%
12.05
-13.37%
13.91
-33.37%
20.88
Other Current Liabilities
39.55
-12.92%
45.41
-6.02%
48.33
-32.39%
71.48
Total Non Current Liabilities Net Minority Interest
28.08
+26.27%
22.24
+33.07%
16.71
-8.41%
18.24
Non Current Deferred Liabilities
4.89
+20.11%
4.07
-10.52%
4.55
+11.82%
4.07
Non Current Deferred Taxes Liabilities
4.89
+20.11%
4.07
-10.52%
4.55
+11.82%
4.07
Other Non Current Liabilities
23.19
+27.66%
18.16
+49.39%
12.16
-14.22%
14.17
Stockholders Equity
533.10
+0.19%
532.11
+7.02%
497.20
+14.44%
434.47
Common Stock Equity
533.10
+0.19%
532.11
+7.02%
497.20
+14.44%
434.47
Capital Stock
0.02
-5.26%
0.02
+0.00%
0.02
+0.00%
0.02
Common Stock
0.02
-5.26%
0.02
+0.00%
0.02
+0.00%
0.02
Share Issued
18.28
-4.11%
19.06
-0.35%
19.13
-0.40%
19.21
Ordinary Shares Number
18.28
-4.11%
19.06
-0.35%
19.13
-0.40%
19.21
Additional Paid In Capital
83.54
+10.19%
75.82
+15.47%
65.66
+18.09%
55.60
Retained Earnings
465.72
-2.76%
478.94
+7.58%
445.22
+13.68%
391.64
Gains Losses Not Affecting Retained Earnings
-16.18
+28.64%
-22.67
-65.53%
-13.70
-7.10%
-12.79
Minority Interest
53.17
-1.95%
54.22
0.00
Other Equity Adjustments
-16.18
+28.64%
-22.67
-65.53%
-13.70
-7.10%
-12.79
Total Equity Gross Minority Interest
586.27
-0.01%
586.33
+17.93%
497.20
+14.44%
434.47
Total Capitalization
533.10
+0.19%
532.11
+7.02%
497.20
+14.44%
434.47
Working Capital
159.84
+14.53%
139.56
-53.31%
298.90
+24.26%
240.55
Invested Capital
547.10
-1.44%
555.11
+11.47%
497.99
+14.62%
434.47
Total Debt
19.65
-32.27%
29.01
+259.78%
8.06
+17.01%
6.89
Capital Lease Obligations
5.65
-6.04%
6.01
-17.38%
7.28
+5.60%
6.89
Net Tangible Assets
261.99
+10.96%
236.12
-47.55%
450.18
+17.03%
384.67
Tangible Book Value
261.99
+10.96%
236.12
-47.55%
450.18
+17.03%
384.67
Line Of Credit
14.00
-39.13%
23.00
+2826.21%
0.79
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
22.35
-63.36%
60.99
-13.66%
70.64
-32.01%
103.90
Cash Flow From Continuing Operating Activities
22.35
-63.36%
60.99
-13.66%
70.64
-32.01%
103.90
Net Income From Continuing Operations
11.48
-72.71%
42.06
-34.06%
63.79
-8.02%
69.35
Depreciation Amortization Depletion
39.70
+78.60%
22.23
+8.99%
20.39
-4.74%
21.41
Depreciation
39.70
+78.60%
22.23
+8.99%
20.39
-4.74%
21.41
Depreciation And Amortization
39.70
+78.60%
22.23
+8.99%
20.39
-4.74%
21.41
Stock Based Compensation
13.83
-5.01%
14.56
-0.25%
14.60
+9.48%
13.33
Asset Impairment Charge
9.65
+410.10%
1.89
-27.30%
2.60
-57.23%
6.08
Deferred Tax
-7.13
-5.77%
-6.74
-145.33%
-2.75
+61.73%
-7.18
Deferred Income Tax
-7.13
-5.77%
-6.74
-145.33%
-2.75
+61.73%
-7.18
Operating Gains Losses
-2.09
-209400.00%
0.00
-90.00%
0.01
-92.91%
0.14
Gain Loss On Sale Of PPE
-2.09
-209400.00%
0.00
-90.00%
0.01
-92.91%
0.14
Change In Working Capital
-43.08
-231.29%
-13.00
+53.56%
-28.00
-3731.52%
0.77
Change In Inventory
-34.69
-1537.63%
-2.12
-190.01%
2.35
-85.10%
15.80
Change In Prepaid Assets
0.62
+121.63%
-2.87
-2710.00%
0.11
+103.33%
-3.30
Change In Payables And Accrued Expense
5.20
+510.09%
-1.27
-196.50%
-0.43
+83.89%
-2.66
Change In Payable
5.20
+510.09%
-1.27
-196.50%
-0.43
+83.89%
-2.66
Change In Account Payable
5.20
+510.09%
-1.27
-196.50%
-0.43
+83.89%
-2.66
Change In Other Current Liabilities
-14.22
-110.79%
-6.75
+77.54%
-30.03
-231.28%
-9.07
Investing Cash Flow
-10.12
+95.25%
-213.09
-1679.46%
-11.97
+3.19%
-12.37
Cash Flow From Continuing Investing Activities
-10.12
+95.25%
-213.09
-1679.46%
-11.97
+3.19%
-12.37
Net PPE Purchase And Sale
-9.92
+0.91%
-10.01
+30.87%
-14.48
-39.31%
-10.39
Purchase Of PPE
-13.82
-37.23%
-10.07
+30.50%
-14.49
-39.37%
-10.40
Sale Of PPE
3.90
+6001.56%
0.06
+326.67%
0.01
+114.29%
0.01
Capital Expenditure
-13.82
-37.23%
-10.07
+30.50%
-14.49
-39.37%
-10.40
Net Investment Purchase And Sale
-1.07
-520.39%
0.26
-89.82%
2.50
-45.03%
4.55
Purchase Of Investment
-1.07
-23.22%
-0.87
+31.55%
-1.27
0.00
Sale Of Investment
0.00
-100.00%
1.12
-70.20%
3.77
-17.12%
4.55
Net Business Purchase And Sale
0.86
+100.43%
-203.34
0.00
+100.00%
-6.53
Purchase Of Business
0.00
+100.00%
-203.34
0.00
+100.00%
-6.53
Net Other Investing Changes
Financing Cash Flow
-40.60
-525.03%
9.55
+167.10%
-14.24
+52.68%
-30.09
Cash Flow From Continuing Financing Activities
-40.60
-525.03%
9.55
+167.10%
-14.24
+52.68%
-30.09
Net Issuance Payments Of Debt
-9.00
-140.50%
22.22
+2705.56%
0.79
0.00
Issuance Of Debt
17.60
-25.70%
23.69
+1436.12%
1.54
-85.98%
11.00
Repayment Of Debt
-26.60
-1713.22%
-1.47
-95.60%
-0.75
+93.18%
-11.00
Short Term Debt Issuance
17.60
-25.70%
23.69
+1436.12%
1.54
-85.98%
11.00
Short Term Debt Payments
-26.60
-1713.22%
-1.47
-95.60%
-0.75
+93.18%
-11.00
Net Short Term Debt Issuance
-9.00
-140.50%
22.22
+2705.56%
0.79
0.00
Net Common Stock Issuance
-27.51
-191.26%
-9.44
+18.58%
-11.60
+54.30%
-25.38
Common Stock Payments
-27.51
-191.26%
-9.44
+18.58%
-11.60
+54.30%
-25.38
Repurchase Of Capital Stock
-27.51
-191.26%
-9.44
+18.58%
-11.60
+54.30%
-25.38
Net Other Financing Charges
-4.10
-27.09%
-3.22
+6.03%
-3.43
+27.11%
-4.71
Changes In Cash
-28.38
+80.09%
-142.54
-420.84%
44.43
-27.69%
61.44
Effect Of Exchange Rate Changes
5.11
+182.53%
-6.19
-147.42%
-2.50
+81.83%
-13.78
Beginning Cash Position
184.51
-44.63%
333.25
+14.39%
291.32
+19.56%
243.65
End Cash Position
161.24
-12.61%
184.51
-44.63%
333.25
+14.39%
291.32
Free Cash Flow
8.53
-83.26%
50.92
-9.31%
56.15
-39.95%
93.50
Interest Paid Supplemental Data
0.66
+772.37%
0.08
+11.76%
0.07
+38.78%
0.05
Income Tax Paid Supplemental Data
40.47
-8.54%
44.25
-3.52%
45.86
Sale Of Business
0.86
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category